Loading
Vimta Labs Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Sireesh Chandra Vungal, was filed 30 Jun 2025.
Vimta Labs Limited: what insiders have been doing
Vimta Labs Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Between 24 October 2025 and 24 October 2026, 1 insider published 1 filing.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 1 filing in twelve months, the company is quieter than the median of 4 filings across the 1,985 companies we follow on the same exchange. Our records for Vimta Labs Limited go back to 2022, with 6 purchases and 29 sales on the open market in total.
Insider buying of Vimta Labs Limited has been absent for the past year.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
35
Thresholds
n/a
Buy Volume
€12M
6 ops. · all time
Sell Volume
€13M
29 ops. · all time
Who traded when
BuySaleHarriman Vungal5 sales
Sujani Vasireddi1 buy3 sales
Suresh Kumar S2 sales
D R Narahai Naidu1 sale
Dhanya Prakash Dhumal1 sale
Dr Muni Nagendra Prasad Poola1 sale
+7 other insiders
Since the insiders bought
- +54.5%Entry ₹449.85 · Close at T+90 ₹694.85
- +54.5%Entry ₹449.85 · Close at T+90 ₹694.85
- +54.5%Entry ₹449.85 · Close at T+90 ₹694.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,882 of 26,290 companies
67.8
score / 100
Value46
Quality90
FCF yld2.1%
Earn yld3.4%
EV/EBITDA15.2x
ROE19%
Gross mgn80%
Net mgn19%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹617.00
Analyst consensus
Income statement
Revenue₹4.1B
Gross profit₹3.3B80% margin
EBITDA₹1.5B36% margin
Net income₹775.1M18.9% margin
Valuation
PER (trailing)34.6x
P/Book6.0x
Beta-0.09
Balance sheet & cash
Market cap₹27.6B
Total debt₹33.3M
Free Cash Flow₹473.4M
Debt / Equity1%
Profitability & ownership
ROE18.6%
ROA12.2%
% insiders65.7%
% institutions4.4%
Last declaration on 27 February 2026
Declarations35 total
5,000 shares@ ₹464.0047.0% of flowEquity SharesSEBI:16cf33cc9ff41ae8242908778efea616a9c6a840
10,000 shares@ ₹649.253.1% of flowEquity SharesSEBI:d232df21ef7bbee4f8fe75cf202ca60751fb00e7
100,000 shares@ ₹438.20100.0% of flowEquity SharesSEBI:0bbe58e628d172f253a144423ba95269f332b8c5
Canonical exit: 25 Sept 2025 (T+90)
250,000 shares@ ₹438.20100.0% of flowEquity SharesSEBI:9763428962525d6ad5742afbd88671dbd8b318e4
Canonical exit: 25 Sept 2025 (T+90)
100,000 shares@ ₹438.20100.0% of flowEquity SharesSEBI:140c42b0a5f2bc0819274318003f9886d71db67b
Canonical exit: 25 Sept 2025 (T+90)
450,000 shares@ ₹438.2094.7% of flowEquity SharesSEBI:e2a56d27e0dd225b618bb2225d41b2a7a040415c
950,000 shares@ ₹976.40100.0% of flowEquity SharesSEBI:2e34c983fc3671527746653cb8313c0575372861
350,000 shares@ ₹976.40100.0% of flowEquity SharesSEBI:6946e66e2db2199f214788f2d9565163913a236e
Canonical exit: 26 Aug 2025 (T+90)
600,000 shares@ ₹976.4096.8% of flowEquity SharesSEBI:bb5c576a5c4025e40e140f37e4b5e78180d664f1
Canonical exit: 26 Aug 2025 (T+90)
2,900 shares@ ₹1,083.65721.7% of flowEquity SharesSEBI:83dcf3b4bc6d8d1b7e64d7e2c8a101f9bb383908
975 shares@ ₹1,038.000.5% of flowEquity SharesSEBI:f2266e6f7ae3a8cfa8429026cac5d5f8856fdaee
1,200 sharesEquity SharesSEBI:3d300bfc8d9e132ec6d046d012c0382ac5a8952b
2,367 shares@ ₹938.6498100.0% of flowEquity SharesSEBI:c9e28c6579a1e32ceaed097d06a3e35ebf3d6eb9
2,000 shares@ ₹768.844.7% of flowEquity SharesSEBI:f69f30d2c54efd9b5850ae29b74e3a1f90c7c844
2,018 shares@ ₹853.112100.0% of flowEquity SharesSEBI:2049a536573f219efb94d9b293447116d69088bf
1,400 shares@ ₹801.650751.0% of flowEquity SharesSEBI:46dcbc3fe845585ea18b7ddb84a4b0cc952c9397
7,000 shares@ ₹828.184917.9% of flowEquity SharesSEBI:75d3c22c33b8cd2b5c066151b40f96c452b22872
5,064 shares@ ₹759.254911.8% of flowEquity SharesSEBI:248bc1bbb31e5cf744d7195c076fb43fb38d0080
886 shares@ ₹760.186232.7% of flowEquity SharesSEBI:57968400224f78b9f3b12bc2522221b1c7084a19
3,659 shares@ ₹767.3471100.0% of flowEquity SharesSEBI:6d345b7ffe0a285f2a2b25820d15ee97663b74c0
1,500 shares@ ₹743.328749.0% of flowEquity SharesSEBI:99a6b71c07e22b61cdebac3b60f55b7046bf6863
2,535 shares@ ₹539.592967.3% of flowEquity SharesSEBI:953834ecc0c4e92a2a5845c37ce2d4e1db11895c
7,153 shares@ ₹492.920910.8% of flowEquity SharesSEBI:e33c0b1d461bb7b713478e31cdb652220861cb64
10,000 shares@ ₹508.560715.3% of flowEquity SharesSEBI:f0bdd048d0225b6fbc1666a07944f3f70afe900c
1,000,000 sharesEquity SharesSEBI:180cd99499537ad2777253522e1810812e6b0af0
25 of 35 declarations
About Vimta Labs Limited
Vimta Labs Limited is a company specializing in research and development services in the healthcare and pharmaceutical sector. It operates in the XBOM market.
